|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00950 LEE'S PHARM
Nominal 
1.160 -0.005 (-0.429%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Turnover | 796,566 | 14.643% | 694,821 | 658,345 | 512,308 | 649,166 |
| Cost of Sales | (349,116) | 4.286% | (334,768) | (307,750) | (227,845) | (229,688) |
| Gross Profit | 447,450 | 24.273% | 360,053 | 350,595 | 284,463 | 419,478 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | (253) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (1,391) | 185.041% | (488) | (239) | (440) | (526) | |
| Profit / (Loss) before Taxation | 86,461 | 42.499% | 60,675 | 61,108 | 27,188 | 51,795 | |
| Taxation | (23,599) | 132.984% | (10,129) | (6,239) | (6,279) | (24,713) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 32,152 | 93.233% | 16,639 | 7,609 | (4,792) | 1,378 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 95,014 | 41.421% | 67,185 | 62,478 | 16,117 | 28,460 | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Net Finance Costs / (Income) | 4,713 | -9.678% | 5,218 | 5,705 | 4,777 | 2,316 |
| Depreciation & Amortisation | 96,638 | 33.940% | 72,150 | 70,452 | 77,747 | 78,536 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 16.140 | 41.455% | 11.410 | 10.610 | 2.740 | 4.830 |
| DPS (cts) | 3.500 | -- | 2.200 | 2.000 | 0.800 | 1.000 |
| Dividend Payout Ratio (%) | 21.685% | -- | 19.281% | 18.850% | 29.197% | 20.704% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 3.609 | -- | 3.300 | 2.910 | 3.352 | 3.637 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 95,014 |
| %Change | 41.421% |
| EPS / (LPS) | HKD 0.161 |
| NBV Per Share ($) | HKD 3.609 |